Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients

Lee, Timothy C; Savoldo, Barbara; Rooney, Cliona M; Heslop, Helen E; Gee, Adrian P; Caldwell, Yvette; Barshes, Neal R; Scott, Jaymee D; Bristow, Lisa J; O'Mahony, Christine A; Goss, John A

doi:10.1111/j.1600-6143.2005.01002.x

Public

Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients.

Published in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons • Sep 1, 2005

NobleIDNI8P18W92R57S75

Authors:

Timothy C Lee

,

Barbara Savoldo

,

Cliona M Rooney

Abstract

Epstein-Barr virus (EBV) is a common viral infection in pediatric liver transplant patients and can lead to development of post-transplant lymphoproliferative disorder (PTLD). Differing studies have used immunosuppression reduction, antiviral medications or i.v. CMV-immunogloublin for EBV prevention...

Discussions